This article provides a detailed analysis of SRF’s financial performance and a monthly SRF share price target 2025.
SRF Limited, a diversified Indian multinational, has consistently demonstrated impressive growth and financial stability.
Given SRF’s historical performance and current market trends, here is a projected monthly share price target for 2025:
Incorporated in 1970, SRF Limited has established itself as a leading manufacturer of technical textiles, chemicals, packaging films, aluminum foils, and other polymers.
The company operates through its diversified business segments, catering to both domestic and international markets.
Analyzing SRF’s quarterly performance offers insights into its operational efficiency and profitability. Below are the consolidated figures in Rs. Crores for the past quarters:
Quarter | Sales | Expenses | Operating Profit | OPM % |
---|---|---|---|---|
Jun 2021 | 2,699 | 2,028 | 672 | 25% |
Sep 2021 | 2,839 | 2,164 | 675 | 24% |
Dec 2021 | 3,346 | 2,464 | 881 | 26% |
Mar 2022 | 3,549 | 2,601 | 948 | 27% |
Jun 2022 | 3,895 | 2,900 | 995 | 26% |
Sep 2022 | 3,728 | 2,959 | 769 | 21% |
Dec 2022 | 3,470 | 2,636 | 834 | 24% |
Mar 2023 | 3,778 | 2,846 | 932 | 25% |
Jun 2023 | 3,338 | 2,642 | 696 | 21% |
Sep 2023 | 3,177 | 2,551 | 626 | 20% |
Dec 2023 | 3,053 | 2,487 | 566 | 19% |
Mar 2024 | 3,570 | 2,874 | 696 | 19% |
Jun 2024 | 3,464 | 2,861 | 603 | 17% |
Quarter | Net Profit | EPS (Rs) |
---|---|---|
Jun 2021 | 395 | 13.35 |
Sep 2021 | 382 | 12.91 |
Dec 2021 | 506 | 17.05 |
Mar 2022 | 606 | 20.43 |
Jun 2022 | 608 | 20.51 |
Sep 2022 | 481 | 16.23 |
Dec 2022 | 511 | 17.24 |
Mar 2023 | 562 | 18.97 |
Jun 2023 | 359 | 12.12 |
Sep 2023 | 301 | 10.15 |
Dec 2023 | 253 | 8.55 |
Mar 2024 | 422 | 14.24 |
Jun 2024 | 252 | 8.51 |
The annual performance of SRF Limited underscores its long-term growth trajectory and profitability.
Year | Sales | Expenses | Operating Profit | OPM % |
---|---|---|---|---|
Mar 2013 | 3,783 | 3,169 | 614 | 16% |
Mar 2014 | 4,018 | 3,513 | 505 | 13% |
Mar 2015 | 4,540 | 3,822 | 717 | 16% |
Mar 2016 | 4,593 | 3,630 | 963 | 21% |
Mar 2017 | 4,822 | 3,852 | 969 | 20% |
Mar 2018 | 5,589 | 4,683 | 906 | 16% |
Mar 2019 | 7,100 | 5,803 | 1,297 | 18% |
Mar 2020 | 7,209 | 5,754 | 1,455 | 20% |
Mar 2021 | 8,400 | 6,267 | 2,133 | 25% |
Mar 2022 | 12,434 | 9,330 | 3,103 | 25% |
Mar 2023 | 14,870 | 11,341 | 3,529 | 24% |
Mar 2024 | 13,139 | 10,554 | 2,584 | 20% |
Year | Net Profit | EPS (Rs) |
---|---|---|
Mar 2013 | 253 | 8.81 |
Mar 2014 | 162 | 5.66 |
Mar 2015 | 303 | 10.55 |
Mar 2016 | 430 | 14.97 |
Mar 2017 | 515 | 17.94 |
Mar 2018 | 462 | 16.08 |
Mar 2019 | 642 | 22.33 |
Mar 2020 | 1,019 | 35.46 |
Mar 2021 | 1,198 | 40.44 |
Mar 2022 | 1,889 | 63.72 |
Mar 2023 | 2,162 | 72.95 |
Mar 2024 | 1,336 | 45.06 |
Period | Promoters | FIIs | DIIs | Public |
---|---|---|---|---|
Sep 2021 | 50.77% | 19.18% | 10.42% | 19.64% |
Dec 2021 | 50.73% | 19.09% | 9.16% | 21.02% |
Mar 2022 | 50.73% | 19.60% | 8.72% | 20.95% |
Jun 2022 | 50.73% | 19.21% | 9.37% | 20.69% |
Sep 2022 | 50.53% | 19.21% | 14.03% | 16.23% |
Dec 2022 | 50.53% | 18.31% | 14.85% | 16.29% |
Mar 2023 | 50.53% | 18.52% | 14.92% | 16.01% |
Jun 2023 | 50.53% | 20.04% | 13.71% | 15.72% |
Sep 2023 | 50.53% | 19.80% | 14.12% | 15.57% |
Dec 2023 | 50.53% | 19.60% | 14.51% | 15.36% |
Mar 2024 | 50.31% | 19.09% | 15.97% | 14.66% |
Jun 2024 | 50.26% | 18.76% | 16.57% | 14.44% |
SRF Limited’s robust financial performance, diverse product portfolio, and strategic market presence make it a compelling investment opportunity.
The company’s consistent growth in sales and profit, along with its solid return on equity, supports a positive outlook for SRF share price target 2025.
Investors should consider SRF’s impressive track record and future potential when making investment decisions.
With these insights, SRF’s share price is expected to continue its upward trajectory, making it a valuable addition to any investment portfolio.
180 Life Sciences Corp. (NASDAQ: ATNF), a biotechnology company, is making a significant shift into…
Morgan Stanley's stock climbed 6% on Wednesday after the bank reported better-than-expected third-quarter earnings. The…
Walgreens, one of the largest pharmacy chains in the U.S., has announced plans to close…
ASML (NASDAQ: ASML), a key player in the semiconductor equipment sector, has issued a disappointing…
Stellantis has announced a recall of 20,755 hybrid SUVs in the U.S. due to a…
Madhya Bharat Agro Products' Q2 FY25 net profit surged to Rs. 11.49 crore, up from…